<DOC>
	<DOCNO>NCT00292370</DOCNO>
	<brief_summary>The purpose study compare response veteran PTSD without optimal response paroxetine quetiapine augmentation versus placebo .</brief_summary>
	<brief_title>Quetiapine Augmentation Treatment-resistant PTSD</brief_title>
	<detailed_description>This two-site study design evaluate efficacy safety quetiapine augmentation paroxetine treatment veteran PTSD fail respond paroxetine treatment . In Phase I , eligible patient take open-label paroxetine ( 60 mg daily ) 8 week . Patients refractory ( less 30 % reduction CAPS score minimum CAPS score 50 week 8 ) PTSD symptom least moderate severity CGI-S eligible second phase . In Phase II , patient continue take open-label paroxetine randomize addition quetiapine ( 800 mg daily ) placebo 8 week double-blind fashion .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Combat Disorders</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Veteran age 18 75 . Competent give inform consent . Meeting DSMIV criterion PTSD . Minimal CAPS score 50 baseline . If female childbearing potential , patient must negative pregnancy test , sexually active , use medically approve contraceptive method . Patients take psychiatric medication within 1 week prior study entry ( except fluoxetine [ 5 week ] ) monoamine oxidase inhibitor ( MAOIs [ 4 week ] ) depot neuroleptic [ 4 week ] ) investigational drug within 30 day prior study enrollment . To eligible Phase II patient must refractory paroxetine Phase I , define less 30 % reduction CAPS score minimum CAPS score 50 week 8 must PTSD symptom least moderate severity CGIS must compliant study medicine Phase I , define take least 80 % prescribed dos . History sensitivity paroxetine quetiapine . Failure respond prior adequate therapeutic trial i.e . minimum 8 week maximum tolerate dose paroxetine ( 60 mg daily ) quetiapine ( 800 mg daily ) . Women breastfeed pregnant expect become pregnant course study sexually active use medically acceptable method birth control . Presence clinically significant hepatic cardiovascular medical condition may prevent safe administration paroxetine quetiapine clinically significant unstable medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Atypical Antipsychotics</keyword>
	<keyword>Controlled Trial</keyword>
	<keyword>Paroxetine</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Stress Disorders , Post-Traumatic</keyword>
	<keyword>Treatment refractory</keyword>
	<keyword>Treatment resistant</keyword>
</DOC>